These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8281199)
1. [Treatment of growth hormone deficiency patients with authentic recombinant growth hormone]. Nery M; Marcondes JA; Lerário AC; Corradini MC; Pacheco AM; Giannela Neto D; Wajchenberg BL Rev Assoc Med Bras (1992); 1993; 39(3):155-60. PubMed ID: 8281199 [TBL] [Abstract][Full Text] [Related]
2. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266 [TBL] [Abstract][Full Text] [Related]
3. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency. Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760 [TBL] [Abstract][Full Text] [Related]
4. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency. Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155 [TBL] [Abstract][Full Text] [Related]
5. Growth response and final height in growth hormone-deficient patients treated with biosynthetic growth hormone. Chen YD; Shu SG; Chi CS Acta Paediatr Taiwan; 2001; 42(5):291-6. PubMed ID: 11729706 [TBL] [Abstract][Full Text] [Related]
6. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency. Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138 [TBL] [Abstract][Full Text] [Related]
7. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency. Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657 [TBL] [Abstract][Full Text] [Related]
8. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children. Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358 [TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation]. Vicens-Calvet E; Seijo G; Potau N; de los Llanos Moreno M; Carrascosa A Med Clin (Barc); 1999 May; 112(16):601-5. PubMed ID: 10374174 [TBL] [Abstract][Full Text] [Related]
10. Regular monitoring of bone age is useful in children treated with growth hormone. Kaufman FR; Sy JP Pediatrics; 1999 Oct; 104(4 Pt 2):1039-42. PubMed ID: 10506261 [TBL] [Abstract][Full Text] [Related]
11. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy. Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002 [TBL] [Abstract][Full Text] [Related]
12. Response to growth hormone therapy in Indian patients. Garg MK; Pakhetra R; Dutta MK; Gundgurthi A Indian J Pediatr; 2010 Jun; 77(6):639-42. PubMed ID: 20532685 [TBL] [Abstract][Full Text] [Related]
13. [Final height in Turner syndrome treated with growth hormone]. Rocchiccioli P; Battin J; Bertrand AM; Bost M; Cabrol S; Le Bouc Y; Chaussain JL; Chatelain P; Job JC; Leheup B Arch Pediatr; 1994 Apr; 1(4):359-62. PubMed ID: 7842089 [No Abstract] [Full Text] [Related]
14. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581 [TBL] [Abstract][Full Text] [Related]
15. [Catch-up growth in growth hormone deficit children treated with GH since the first year of life]. Huet F; Carel JC; Nivelon JL; Chaussain JL Arch Pediatr; 1998; 5 Suppl 4():318S-321S. PubMed ID: 9853076 [TBL] [Abstract][Full Text] [Related]
16. The results of long-term growth hormone replacement therapy in Turkish children with growth hormone deficiency. Yordam N; Kandemir N; Alikaşifoğlu A Turk J Pediatr; 1998; 40(1):55-60. PubMed ID: 9673529 [TBL] [Abstract][Full Text] [Related]
17. Long-term auxologic effects of human growth hormone. Bundak R; Hindmarsh PC; Smith PJ; Brook CG J Pediatr; 1988 Jun; 112(6):875-9. PubMed ID: 3373391 [TBL] [Abstract][Full Text] [Related]
18. Predicting and monitoring of growth in children with short stature during the first year of growth hormone treatment. Mortensen HB; Main K; Michaelsen KF; Kastrup KW; Jłrgensen JT; Skakkebaek NE Acta Paediatr Scand; 1991 Dec; 80(12):1150-7. PubMed ID: 1785287 [TBL] [Abstract][Full Text] [Related]
19. The combined effect of growth hormone and oxandrolone in patients with growth hormone deficiency. Romshe CA; Sotos JF J Pediatr; 1980 Jan; 96(1):127-31. PubMed ID: 7350292 [TBL] [Abstract][Full Text] [Related]
20. An auxology-based growth hormone program: update on the Australian experience. Werther GA; Wang M; Cowell CT J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():613-8. PubMed ID: 12795362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]